Loading stock data...

Nexus Surgical & Medicare Ltd.

BSE: NEXUSSURGL

BSE
19.85 2.52 (14.54%)

Prev Close

17.33

Open Price

17.33

Volume

2,350

Today Low / High

17.33 / 19.99

52 WK Low / High

13.26 / 22

Range

19 - 21

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 19.85, reflecting a change of 2.52 (14.54126%). The expected target range on the BSE is 19 - 21. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

20 Feb 17.26 10.02%
19 Feb 18.31 -5.73%
18 Feb 19.12 -3.77%
17 Feb 17.11 0.06%
16 Feb 17.11 0.00%
13 Feb 16.01 6.87%
12 Feb 18.90 -7.41%
11 Feb 18.99 0.00%
10 Feb 19.60 -13.27%
09 Feb 18.00 -8.22%
06 Feb 17.50 0.00%
05 Feb 17.31 1.10%
04 Feb 17.40 -0.52%
03 Feb 17.50 0.00%
02 Feb 17.01 -0.12%
01 Feb 17.75 0.00%
30 Jan 18.00 -1.39%
29 Jan 16.98 0.00%
28 Jan 16.90 0.47%

Nexus Surgical & Medicare Ltd. Graph

Nexus Surgical & Medicare Ltd. Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Nexus Surgical & Medicare Ltd. T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 19.85, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 19.85 20.05 18.04 - 22.05
20.25 16.20 - 24.30
20.45 14.31 - 26.58
Bearish Scenario 19.85 19.65 17.69 - 21.62
19.45 15.56 - 23.34
19.25 13.48 - 25.03

Overview of Nexus Surgical & Medicare Ltd.

ISIN

INE370Q01015

Industry

Medical - Distribution

Vol.Avg

1,539

Market Cap

103,911,381

Last Dividend

0

Official Website

Visit Website

IPO Date

2024-12-30

DCF Diff

-34.17

DCF

53

Financial Ratios Every Investor Needs

Stock Rating Details for NEXUSSURGL

Metric Value Recommendation
Overall Rating C+ Sell
DCF Score 5 Strong Buy
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 5.72 Cr 2.28 Cr 3.44 Cr 0.6018 0.00 Cr 0.00 Cr 0.66 Cr 0.50 Cr 0.92 0.68 Cr 0.0869
2024-03-31 3.47 Cr 0.84 Cr 2.64 Cr 0.7595 0.00 Cr 1.91 Cr 0.29 Cr 0.21 Cr 0.39 0.29 Cr 0.0614
2023-03-31 1.55 Cr 0.71 Cr 0.85 Cr 0.5459 0.00 Cr 0.38 Cr 0.22 Cr 0.17 Cr 0.31 0.22 Cr 0.1099
2022-03-31 2.40 Cr 0.23 Cr 2.17 Cr 0.9055 0.00 Cr 1.65 Cr 0.37 Cr 0.29 Cr 0.53 0.37 Cr 0.1212
2021-03-31 3.74 Cr 1.35 Cr 2.40 Cr 0.6404 0.00 Cr 0.81 Cr 0.16 Cr 0.15 Cr 0.28 0.16 Cr 0.0411

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.33 Cr 2.27 Cr 1.21 Cr 1.0636 Cr 0.00 Cr -0.33 Cr 0.43 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.2109 Cr
2024-03-31 0.23 Cr 1.81 Cr 1.24 Cr 0.5663 Cr 0.00 Cr -0.23 Cr 0.40 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.2400 Cr
2023-03-31 0.35 Cr 0.92 Cr 0.56 Cr 0.3529 Cr 0.00 Cr -0.35 Cr 0.10 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.5626 Cr
2022-03-31 0.11 Cr 2.00 Cr 1.82 Cr 0.1822 Cr 0.00 Cr -0.11 Cr 0.43 Cr 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.8215 Cr
2021-03-31 0.22 Cr 0.93 Cr 1.04 Cr -0.1080 Cr 0.00 Cr -0.22 Cr 0.00 Cr 0.02 Cr 0.00 Cr 0.00 Cr 0.00 Cr 1.0430 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 0.1032 Cr -0.0071 Cr 0.0000 Cr 0.0961 Cr 0.0972 Cr 0.3313 Cr -0.0071 Cr 0.4974 Cr 0.0000 Cr 0.0000 Cr -0.0266 Cr
2024-03-31 -0.4140 Cr -0.0030 Cr 0.0000 Cr -0.4170 Cr -0.1170 Cr 0.0023 Cr -0.0030 Cr 0.2133 Cr 0.0000 Cr 0.0000 Cr -0.3315 Cr
2023-03-31 0.5497 Cr -0.0063 Cr 0.0000 Cr 0.5433 Cr 0.2433 Cr 0.0065 Cr -0.0063 Cr 0.1707 Cr 0.0000 Cr 0.0000 Cr 0.0035 Cr
2022-03-31 -0.1106 Cr -0.0011 Cr 0.0000 Cr -0.1117 Cr -0.1117 Cr 0.1078 Cr -0.0011 Cr 0.2902 Cr 0.0000 Cr 0.0000 Cr -0.4257 Cr
2021-03-31 0.1986 Cr 0.0000 Cr 0.0000 Cr 0.1986 Cr 0.1986 Cr 0.2195 Cr 0.0000 Cr 0.1704 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 2.93 Cr 0.66 Cr 2.27 Cr 0.7741 0.23 Cr 0.17 Cr 0.31 0.23 Cr 0.0580
2025-09-30 1.17 Cr 0.72 Cr 0.45 Cr 0.3845 0.23 Cr 0.17 Cr 0.32 0.23 Cr 0.1490
2025-06-30 1.73 Cr 0.70 Cr 1.03 Cr 0.5965 0.20 Cr 0.15 Cr 0.28 0.20 Cr 0.0884
2025-03-31 1.48 Cr 0.91 Cr 0.57 Cr 0.3866 0.11 Cr 0.09 Cr 0.16 0.11 Cr 0.0596
2024-12-31 1.48 Cr 0.34 Cr 1.14 Cr 0.7690 0.15 Cr 0.11 Cr 0.21 0.15 Cr 0.0766

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.17 Cr 0.04 Cr 0.21 Cr 1.22 Cr 0.43 Cr 2.30 Cr 0.02 Cr 2.33 Cr 0.94 Cr
2025-03-31 0.33 Cr 0.04 Cr 0.37 Cr 1.34 Cr 0.43 Cr 2.24 Cr 0.02 Cr 2.27 Cr 1.21 Cr
2024-09-30 0.08 Cr 0.04 Cr 0.12 Cr 1.46 Cr 0.32 Cr 2.01 Cr 0.03 Cr 2.05 Cr 1.18 Cr
2024-03-31 0.23 Cr 0.00 Cr 0.23 Cr 0.86 Cr 0.50 Cr 1.75 Cr 0.02 Cr 1.81 Cr 1.24 Cr
2023-09-30 0.66 Cr 0.00 Cr 0.66 Cr 0.31 Cr 0.20 Cr 1.33 Cr 0.02 Cr 1.39 Cr 0.93 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2023-12-31 0.05 Cr 0.05 Cr 0.00 Cr 0.00 Cr -0.62 Cr 0.05 Cr 0.66 Cr 0.00 Cr 0.05 Cr
2023-09-30 0.08 Cr 0.08 Cr 0.00 Cr 0.00 Cr 0.08 Cr 0.66 Cr 0.58 Cr 0.00 Cr 0.08 Cr
2023-06-30 0.03 Cr 0.03 Cr 0.00 Cr 0.00 Cr -0.32 Cr 0.03 Cr 0.35 Cr 0.00 Cr 0.03 Cr
2023-03-31 -0.10 Cr -0.10 Cr 0.00 Cr 0.00 Cr -0.10 Cr 0.35 Cr 0.45 Cr 0.00 Cr -0.10 Cr
2022-12-31 0.14 Cr 0.14 Cr 0.00 Cr 0.00 Cr -0.25 Cr 0.14 Cr 0.39 Cr 0.00 Cr 0.14 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Distribution

Company Name Symbol Price Market Cap Volume
Entero Healthcare Solutions Limited ENTERO ₹1,028.30 ₹44,742,296,517.00 ₹88,798.00

Key Executives

Chief Financial Officer & Executive Director
Pawankumar Sitaram Choudhary

Gender: male

Year Born: 1955

Chairman & MD
Ram Swaroop Mahadev Joshi

Gender: male

Year Born: 1961

Company Secretary & Compliance Officer
Monika Choudhary

Gender: female

Year Born:

FAQs about Nexus Surgical & Medicare Ltd.

Who is the CEO of the company?

The CEO is Ram Swaroop Mahadev Joshi.

What is the current market price of the stock?

The current price is ₹18.99.

What is the 52-week price range?

The range is ₹13.26-22.

What is the market capitalization of the company?

The market capitalization is ₹10.39 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 17.77.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Nexus Surgical & Medicare Ltd. (ISIN: INE370Q01015) is a leading Medical - Distribution in India. With a market capitalization of ₹10.39 crores and an average daily volume of 1,539 shares, it operates in the Medical - Distribution. The company last declared a dividend of ₹0.